Shl Telemedicine Ltd.

As of June 30, 2015, Shl Telemedicine Ltd. carries a market capitalization of 102.81M, placing it among publicly traded companies globally. Its enterprise value stands at 111.60M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2015, Shl Telemedicine Ltd. has 19.07M shares outstanding.

As of June 30, 2015, Shl Telemedicine Ltd. trades at a trailing price-to-earnings ratio of 124.32. The price-to-sales ratio is 2.87, and the price-to-book ratio stands at 1.80.

As of June 30, 2015, Shl Telemedicine Ltd. trades at an EV/EBITDA multiple of 37.76 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.97 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 79.40 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Shl Telemedicine Ltd. trades at an EV/FCF ratio of 156.13, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 111.60M versus a market cap of 102.81M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2015, Shl Telemedicine Ltd. maintains a current ratio of 1.82, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 36.17, indicating elevated leverage, while an interest coverage ratio of 2.47 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2015, Shl Telemedicine Ltd. posted a return on equity (ROE) of 1.43, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 0.83 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 0.92, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 1.74, useful for judging operating efficiency across full business cycles. The company generates approximately 83,649.89 in revenue per employee across its workforce of 448.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 8.19 indicates how many times Shl Telemedicine Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2015, Shl Telemedicine Ltd. recorded 880,355.52 in income tax expense. That works out to an effective tax rate of 50.40, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.75M, leaving 866,337.12 in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Shl Telemedicine Ltd.'s stock has gained approximately 62.12% over the past 52 weeks. The 50-day moving average sits at 1.05, while the 200-day moving average is 1.04.

Over the twelve months ended June 30, 2015, Shl Telemedicine Ltd. generated 37.52M in revenue and converted that into 866,337.12 in net income, yielding earnings per share of 0.04. EBITDA reached 2.96M, while operating income came in at 1.89M.

As of June 30, 2015, Shl Telemedicine Ltd. holds 11.90M in cash and equivalents against 20.70M in total debt, resulting in a net debt position of 13.18M. Total book value stands at 57.23M, with working capital of 15.08M providing operational flexibility.

Shl Telemedicine Ltd. produced 4.26M in operating cash flow over the twelve months ended June 30, 2015. After subtracting -4.14M in capital expenditures, free cash flow totaled 120,558.24 - equivalent to 0.01 per share.

Over the twelve months ended June 30, 2015, Shl Telemedicine Ltd. posted a gross margin of 54.20, reflecting its pricing power and cost economics. The operating margin of 5.05 and net profit margin of 2.31 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2015. Free cash flow yield stands at 0.11, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.19, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Shl Telemedicine Ltd. shareholders.

Shl Telemedicine Ltd.'s most recent stock split took place on November 25, 2025 with a 11:20 split ratio.

As of June 30, 2015, Shl Telemedicine Ltd. has an Altman Z-Score of 2.33, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.